Looking for a potential run-up heading into the PDUFA announcement on 30-Dec.
Reasoning: Ex-CEO David Dodd left the company just before a lawsuit was launched against him for trying to obtain personal rights for the lead drug candidate Macrilen. For him to act in such a way, its quite possible that he see good future potential for the product.
Buy zone: $1.60 - $1.80 Profit zone: $2.60 or higher Stop zone: $1.40 or lower
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.